Insider Stock Trading History of Christensen Jamie


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Christensen Jamie since year 2005. The trader's CIK number is 1599324. At the time of this reporting, Christensen Jamie is the SVP, Chief Science Officer of Mirati Therapeutics, Inc. . (stock ticker symbol MRTX). See this page for all insider trading activities at Mirati Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Christensen Jamie since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-11-16 MRTX Mirati Therapeutics, Inc. Option Ex 10,000 8.50 85,000
2017-11-16 MRTX Mirati Therapeutics, Inc. Sale 10,275 18.00 184,950
2017-11-02 MRTX Mirati Therapeutics, Inc. Option Ex 7,499 5.50 41,244
2017-11-02 MRTX Mirati Therapeutics, Inc. Sale 7,499 14.00 104,986
2017-10-04 MRTX Mirati Therapeutics, Inc. Option Ex 4,000 8.50 34,000
2017-10-04 MRTX Mirati Therapeutics, Inc. Sale 4,000 14.00 56,000
2017-09-15 MRTX Mirati Therapeutics, Inc. Sale 770 12.00 9,240
2015-05-26 MRTX Mirati Therapeutics, Inc. Option Ex 4,750 17.41 82,697
2015-05-26 MRTX Mirati Therapeutics, Inc. Sale 4,750 28.07 133,337
2015-03-05 MRTX Mirati Therapeutics, Inc. Option Ex 6,000 8.50 51,000
2015-03-05 MRTX Mirati Therapeutics, Inc. Sale 6,000 25.59 153,570
2015-02-17 MRTX Mirati Therapeutics, Inc. Option Ex 400 8.50 3,400
2015-02-17 MRTX Mirati Therapeutics, Inc. Sale 1,650 22.70 37,446
2015-02-19 MRTX Mirati Therapeutics, Inc. Option Ex 3,100 8.50 26,350
2015-02-19 MRTX Mirati Therapeutics, Inc. Sale 3,100 23.02 71,377
2014-12-05 MRTX Mirati Therapeutics, Inc. Option Ex 2,500 8.50 21,250

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Christensen Jamie (SVP, Chief Science Officer of Mirati Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.